In addition, they were more likely to have increased levels of triglyceride and LDL at admission, an increased frequency of a history of hypertension, and an increased possibility of being large arterial atherosclerosis, developing pulmonary infection, and receiving oral hypoglycaemic drugs, insulin, and antihypertensive drugs, compared with normal glucose regulation patients. The gene discussed is INS; the disease is atherosclerosis.